Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study
Ian Pearce
(1)
,
Andreas Clemens
(2)
,
Michael Brent
(3)
,
Lin Lu
(4)
,
Roberto Gallego-Pinazo
(5)
,
Angelo Maria Minnella
(6)
,
Catherine Creuzot-Garcher
(7)
,
Georg Spital
(8)
,
Taiji Sakamoto
(9)
,
Cornelia Dunger-Baldauf
(2)
,
Ian Mcallister
(10, 11)
,
On Behalf of All The Luminous Study Investigators
1
Saint Paul's Eye Unit
2 Novartis Pharma AG
3 University of Toronto
4 Graphics Group
5 Oftalvist Clinic
6 Unicatt - Università cattolica del Sacro Cuore = Catholic University of the Sacred Heart [Roma]
7 Service d'Ophtalmologie (CHU de Dijon)
8 St. Franziskus Hospital
9 Kagoshima University Graduate School of Medical and Dental Sciences
10 UWA - The University of Western Australia
11 Royal Perth Hospital
2 Novartis Pharma AG
3 University of Toronto
4 Graphics Group
5 Oftalvist Clinic
6 Unicatt - Università cattolica del Sacro Cuore = Catholic University of the Sacred Heart [Roma]
7 Service d'Ophtalmologie (CHU de Dijon)
8 St. Franziskus Hospital
9 Kagoshima University Graduate School of Medical and Dental Sciences
10 UWA - The University of Western Australia
11 Royal Perth Hospital
Andreas Clemens
Connectez-vous pour contacter l'auteur
- Fonction : Auteur correspondant
- PersonId : 1089151
Connectez-vous pour contacter l'auteur
Catherine Creuzot-Garcher
- Fonction : Auteur
- PersonId : 760739
- ORCID : 0000-0002-3587-4598
On Behalf of All The Luminous Study Investigators
- Fonction : Auteur